BACKGROUND: Recent genome-wide association studies in East Asians have identified polymorphisms in KCNQ1 as new type 2 diabetes risk variants. The aim of this study was to investigate whether variants in KCNQ1 are associated with development of gestational diabetes mellitus (GDM) and measures of oral glucose tolerance test (OGTT) at the time of diagnosis of GDM. METHODS: Three candidate single nucleotide polymorphisms (rs2074196, rs2237892, and rs2237895) were genotyped in 869 Korean GDM women and 632 nondiabetic control subjects. Insulin resistance was estimated by homeostasis model assessment and pancreatic β-cell function by the insulinogenic index at 1 h. RESULTS: rs2074196 and rs2237892 were associated with the risk of GDM (OR 1.17, 95% CI 1.01-1.36, p = 0.039; OR 1.24, 95% CI 1.07-1.45, p = 0.0049). Furthermore, rs2237892 and rs2237895 were nominally associated with a decreased insulinogenic index at the time of GDM diagnosis (p = 0.025 and p = 0.037), whereas no association was observed with measures of insulin resistance. CONCLUSIONS: The single nucleotide polymorphisms in KCNQ1 showed a significant association with GDM in the Korean population. Although the mechanism is not yet clear, it could be possible that variants in KCNQ1 confer a risk for GDM by altering pancreatic β-cell function.
BACKGROUND: Recent genome-wide association studies in East Asians have identified polymorphisms in KCNQ1 as new type 2 diabetes risk variants. The aim of this study was to investigate whether variants in KCNQ1 are associated with development of gestational diabetes mellitus (GDM) and measures of oral glucose tolerance test (OGTT) at the time of diagnosis of GDM. METHODS: Three candidate single nucleotide polymorphisms (rs2074196, rs2237892, and rs2237895) were genotyped in 869 Korean GDM women and 632 nondiabetic control subjects. Insulin resistance was estimated by homeostasis model assessment and pancreatic β-cell function by the insulinogenic index at 1 h. RESULTS:rs2074196 and rs2237892 were associated with the risk of GDM (OR 1.17, 95% CI 1.01-1.36, p = 0.039; OR 1.24, 95% CI 1.07-1.45, p = 0.0049). Furthermore, rs2237892 and rs2237895 were nominally associated with a decreased insulinogenic index at the time of GDM diagnosis (p = 0.025 and p = 0.037), whereas no association was observed with measures of insulin resistance. CONCLUSIONS: The single nucleotide polymorphisms in KCNQ1 showed a significant association with GDM in the Korean population. Although the mechanism is not yet clear, it could be possible that variants in KCNQ1 confer a risk for GDM by altering pancreatic β-cell function.
Authors: Soo Heon Kwak; Sung-Hoon Kim; Young Min Cho; Min Jin Go; Yoon Shin Cho; Sung Hee Choi; Min Kyong Moon; Hye Seung Jung; Hyoung Doo Shin; Hyun Min Kang; Nam H Cho; In Kyu Lee; Seong Yeon Kim; Bok-Ghee Han; Hak C Jang; Kyong Soo Park Journal: Diabetes Date: 2012-01-10 Impact factor: 9.461
Authors: C J Petry; K Mooslehner; P Prentice; M G Hayes; M Nodzenski; D M Scholtens; I A Hughes; C L Acerini; K K Ong; W L Lowe; D B Dunger Journal: Diabetes Metab Date: 2017-04-06 Impact factor: 6.041